GAIL Limited on Tuesday, May 13, announced a final dividend of 10% along with its fourth quarter earnings for the financial year 2024-25 (FY25).

Novo Nordisk has potential with a 27% upside, strong market shares, and high ROI strategies. See why we recommend a buy on ...